Seven individuals have been selected by the College’s Awards Committee to receive ACCP’s prestigious 2026 awards, recognizing excellence in clinical pharmacy. Sally A. Arif, Larisa H. Cavallari, John W. Devlin, Elizabeth Anne Farrington, Jennifer K. McDermott, Nancy L. Shapiro, and Joanna Stollings will be honored with the Excellence in Advancement of Diversity, Health Equity, Inclusion, and Accessibility (DEIA) Award; the Russell R. Miller Award; the Therapeutic Frontiers Lecture Award; the Robert M. Elenbaas Service Award; the C. Edwin Webb Professional Advocacy Award; the Education Award; and the Clinical Practice Award, respectively. Farrington and McDermott will be recognized during the Welcome & Keynote Address on Saturday morning, October 17, and the remaining recipients will be honored during the Awards Ceremony on Sunday morning, October 18, at the 2026 ACCP Annual Meeting in Salt Lake City.

The Excellence in Advancement of DEIA Award recognizes outstanding leadership in advancing diversity, equity, inclusion, and accessibility in pharmacy education, practice, research, or advocacy. Sally A. Arif, Pharm.D., BCCP, is a tenured professor of pharmacy at Midwestern University College of Pharmacy and a clinical cardiology pharmacist and health equity advocate at Rush University Medical Center. Arif is also the founder and CEO of The Equity-Minded Collective, a consultancy established to address systemic inequities and support communities that are marginalized within health care and higher education.

In recommending Arif for the 2026 Excellence in Advancement of DEIA Award to the ACCP Board of Regents, the Awards Committee wrote:

Drawing on nearly 2 decades of health care experience, she integrates equity-minded strategies through her pedagogy in the classroom and in clinical and experiential settings. Within ACCP, Dr Arif has been a highly active member of the DEIA Committee, serving as vice chair from 2024-2025. She contributed directly to the development of the ACCP DEIA Toolkit, proposed the creation of affinity groups, and spearheaded the development of guidance documents to integrate DEIA principles into ACCP mentoring programs.

Arif’s expertise is recognized globally through more than 80 platform presentations, media interviews, and peer-reviewed posters focused on DEIA. She has received numerous awards, including Teacher of the Year, Preceptor of the Year, and Outstanding Advisor.

The Russell R. Miller Award, named for the founding editor of Pharmacotherapy, honors significant contributions to the clinical pharmacy literature that advance practice and rational pharmacotherapy. Larisa H. Cavallari, Pharm.D., FCCP, FAHA, is a tenured professor and chair of the Department of Pharmacotherapy and Translational Research and holds the Debbie DeSantis Excellence Professorship at the University of Florida College of Pharmacy in Gainesville, Florida. At the time of her nomination, Cavallari had written 167 original research articles and 287 original publications, including review articles, book chapters, and commentaries, resulting in an h-index of 60, i-10 index of 174, and over 12,000 citations.

In recommending Cavallari for the 2026 Russell R. Miller Award to the ACCP Board of Regents, the Awards Committee wrote:

Dr Cavallari has made exceptional and sustained contributions to the clinical pharmacy literature, particularly in the field of pharmacogenomics and precision medicine. Her work has directly informed CPIC pharmacogenomic guidelines and major cardiovascular pharmacotherapy recommendations, including genotype-guided antiplatelet therapy and warfarin pharmacogenetics. In addition to an extensive body of original research published in high-impact journals such as The Lancet, JACC, and Nature Reviews Cardiology, she has contributed extensively to textbooks and invited editorials. Collectively, her work demonstrates sustained and highly influential contributions to the professional literature of clinical pharmacy.

Cavallari is an active ACCP member and Fellow who previously served on the ACCP Board of Regents and ACCP Research Institute Board of Trustees. She has also held leadership roles on several ACCP committees, including chair of the Educational Affairs Committee and secretary of the Research Affairs, Education, and Nominations committees. Her contributions to ACCP journals include 45 publications in Pharmacotherapy and 16 in the Journal of the American College of Clinical Pharmacy, and she previously served on the Pharmacotherapy editorial board.

The ACCP Therapeutic Frontiers Lecture Award is presented to an individual at the forefront of pharmacotherapeutics whose groundbreaking work has advanced therapeutic research. John W. Devlin, Pharm.D., FCCP, MCCP, BCCCP, is a tenured professor at Northeastern University School of Pharmacy. He also practices at Brigham and Women’s Hospital, where he serves as an associate scientist in the division of Pulmonary and Critical Care Medicine, a critical care pharmacist in the Department of Pharmacy, and an instructor in medicine at Harvard Medical School. Devlin is an internationally recognized researcher whose substantial contributions to critical care medicine have made a lasting impact on outcomes for critically ill patients.

In its report to the Board of Regents, the Awards Committee shared:

Dr Devlin has secured approximately $5 million in grant funding, with support from industry, federal, international and professional societies funding agencies for over 20 straight years. He is renowned for his sustained record of accomplishment of innovative, cutting-edge research investigating strategies focused on recognizing and reducing agitation, delirium, and disrupted sleep to lessen post-intensive care unit syndrome and improve ICU survivorship.

In 2020, Devlin was elected a Master of Critical Care Medicine (MCCM) by the Society of Critical Care Medicine, the society’s highest level of recognition. This prestigious honor recognizes individuals who have achieved international professional prominence and made significant contributions to the field of critical care, with Devlin among the first pharmacists to receive the distinction. He received ACCP Fellow recognition in 2005. He will deliver his Therapeutic Frontiers Lecture, “Purpose and Passion: Reducing Delirium in Critically Ill Adults,” during the Awards Ceremony in Salt Lake City on October 18.

Robert M. Elenbaas served as ACCP’s founding executive director from 1986 through 2003. During his 17-year tenure, he exemplified the characteristics of a servant-leader committed to the advancement of clinical pharmacy and ACCP. The Elenbaas Service Award is given only when a particularly noteworthy candidate is identified in recognition of outstanding contributions to the vitality of ACCP or the advancement of its goals that go well above the usual devotion of time, energy, or material goods. Elizabeth Anne Farrington, Pharm.D., FCCP, FCCM, FPPA, BCPS, BCNSP, BCPPS, is a clinical pharmacist at New Hanover Regional Medical Center.

In her letter of support, Dr Allison Beck Blackmer, adjunct associate professor at Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, shared:

It is difficult to enumerate all of the ways that Elizabeth has contributed to the vitality of ACCP due to the fact that her contributions are so vast. She has been an active member of ACCP since the mid-1980s and was instrumental in the development of and service to local chapters (ie, Indiana College of Clinical Pharmacy and Triangle College of Clinical Pharmacy). Elizabeth has served on nearly all of the ACCP committees throughout her career and served as the first chair of the Pediatrics Practice and Research Network (PRN). Of greatest note related to her high-level service within the College has been her membership on the Board of Regents and her service as president-elect, president, and past-president of ACCP. Certainly, whether you know Elizabeth personally or not, all ACCP members view Elizabeth as a leader at ACCP and as a recognizable face, force, and role model.

Dr Lucas Orth, assistant professor at Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, shared in his letter of nomination how Farrington has remained committed to ACCP’s goal of advancing clinical pharmacists:

Her external contributions to various areas of ACCP’s goals, strategic plan, and the general advancement of clinical pharmacy are extremely deserving of further discussion. Dr Farrington participated in committee work related to public and professional relations and pharmacist board certification throughout the 1990s, when only 4 certifications existed. Throughout her career, Dr Farrington has been an outspoken advocate for recognition of additional specialties, as evidenced by her service on the Board of Pharmacy Specialties pediatric pharmacy practice analysis task force in 2011 and her leadership to the Pediatric Specialty Council as vice chair and chair from 2013 to 2017. Her advocacy was vital to the creation of the BCPPS certification in 2014, which is now held by over 1800 pediatric pharmacists.

In recognition of her commitment to and excellence in the profession, Farrington has received many prestigious awards, including multiple Presidential Citations from the Society of Critical Care Medicine, the BPS Weaver/Penna Award from the Board of Pharmacy Specialties, and the Nelms-Berg Department Editor Award from the Journal of Pediatric Health Care. She was recognized as an ACCP Fellow in 1997.

The C. Edwin Webb Professional Advocacy Award is given only when a particularly noteworthy candidate is identified who has made outstanding contributions to the visibility and value of clinical pharmacy in national policy, intraprofessional, and interprofessional arenas; has assembled a record of mentoring others who have gone on to assume a health professions and health policy leadership role; and is recognized as an ambassador for clinical pharmacy both within and outside the profession. Jennifer K. McDermott, Pharm.D., FCCP, FAST, BCTXP, BCPS, is a pharmacist with the Centers for Medicare & Medicaid Services within the US Department of Health and Human Services, where she works in the Division of Formulary and Benefit Operations of the Medicare Drug Benefit and C&D Data Group.

Dr Karen A. Khalil, senior project manager at NYU Langone Transplant Institute, shared in her letter of nomination that McDermott’s record is “exemplary.” She wrote:

Her work has directly improved access to essential therapies, elevated the role of clinical pharmacists in policy conversations, and inspired others to engage in advocacy on behalf of their patients and the profession. One of her most important contributions to the field has been leading the effort to expand immunosuppressive drug coverage under Medicare Part B, which was incorporated into the CY2025 Medicare Physician Fee Schedule Final Rule. This work has improved access to life-saving therapies for transplant recipients and clearly demonstrated the value of clinical pharmacists in shaping, implementing, and evaluating national policy.

Dr Maya Campara, coordinator of transplant clinical pharmacy services at UI Health, spoke to McDermott’s mentorship and leadership in her letter of support:

Dr McDermott’s mentorship record is long, sustained, and deeply impactful. She has served as a primary preceptor for dozens of pharmacy residents and students across several major academic medical centers and has mentored early-career clinicians through national programs within the AST Trainee and Young Faculty Community of Practice. Many of her mentees have since assumed leadership roles in transplant pharmacy, academia, and clinical practice.

Her influence is also evident through her scholarship. As series editor for SOTSAP, she shapes the professional development of practitioners nationwide. Her authorship of consensus guidelines—endorsed jointly by ACCP, AST, and ISHLT—further reflects her leadership in guiding the profession’s direction.

An ambassador for clinical pharmacy, McDermott is a frequently invited speaker at the American Transplant Congress, ACCP, ASHP, and CMS, where she addresses topics such as immunosuppression, transplant medication access, Medicare policy, and best practices in clinical care. She has received many awards, including the AST Most Valuable Pharmacist Award, Wiley Top Cited Article Co-Author, and ACCP Fellow recognition in 2025.

The ACCP Education Award recognizes excellence and lasting impact in clinical pharmacy education at the professional or postgraduate level. Nancy L. Shapiro, Pharm.D., FCCP, BCACP, CACP, is an associate head for education and clinical professor in the Department of Pharmacy Practice at the University of Illinois Chicago Retzky College of Pharmacy. She also serves as an ambulatory care clinical pharmacist and operations coordinator for the Antithrombosis Clinic at the University of Illinois Hospital and Health Sciences System.

In recommending Shapiro for the 2026 ACCP Education Award, the Awards Committee wrote:

With more than 30 years of impactful service in pharmacy education, Dr Shapiro has made significant contributions to the training of pharmacy students, residents, and practicing pharmacists. Her educational impact spans local to international audiences through her extensive interprofessional continuing education. She has led major initiatives as program chair, planner, moderator, and faculty for national certificate programs, specialty conferences, and preceptor development programs. She also founded and led international pharmacy education programs, including a summer program that has trained more than 500 learners from over 25 universities across Asia and Europe.

A lifelong educator, Shapiro continues to innovate in the classroom and advance pharmacy education. She is actively involved in several professional organizations, including ACCP, where she has served on the Awards Committee and Board of Regents and as a member of the Public and Professional Relations Committee and Education and Training PRN. She was recognized as an ACCP Fellow in 2010. Through her dedication to pharmacy education and professional service, Shapiro exemplifies the mission of the ACCP Education Award and has made a lasting impact on the training and development of future clinical pharmacists.

The ACCP Clinical Practice Award honors substantial and sustained contributions to innovative clinical pharmacy practice and patient care. Joanna Stollings, Pharm.D., FCCP, FCCM, BCPS, BCCP, is an MICU clinical pharmacy specialist at Vanderbilt University Medical Center. With more than 20 years of experience in critical care, Stollings has played a pivotal role in expanding clinical pharmacy services and strengthening the role of pharmacists in critical care practice.

In its report to the ACCP Board of Regents, the Awards Committee commented:

Stollings expanded clinical pharmacy services to include the development of and research conducted with the Critical Illness Brain Dysfunction Survivorship Center (CIBS) and ICU-Recovery Center at Vanderbilt. She has contributed extensively to research and scholarly endeavors and has been an investigator for several landmark trials that have contributed to changes in critical care practice, including MIND-USA, SMART, and PILOT, each published in The New England Journal of Medicine.

Stollings’ scholarly contributions include more than 100 peer-reviewed publications, an h-index of 38, and more than 200 external presentations. She has been recognized nationally for her patient- and family-centered approach to critical care management, including through the incorporation of her work into national guidelines such as the SCCM Guidelines on Family-Centered Care for Adult ICUs. She was recognized as an ACCP Fellow in 2016.

Members of the 2026 Awards Committee were Melanie Claborn (chair), Paul Gubbins (vice chair), Scott Bolesta, Allison Chung, Lawrence Cohen, Brandon Dionne, Amy Fabian, Stormi Gale, Carrie Griffiths, Christine Groth, Payal Gurnani, Zhe Han, Erin Hennessey, Miranda Howland, Kazuhiko Kido, Eric Kinney, Wesley Kufel, Dustin Linn, Tanvi Patil, Marissa Salvo, Angela Shogbon Nwaesei, Harminder Sikand, and Yi Zhou.